Crefmirlimab, CAS 2611099-93-3

Product Description: Crefmirlimab (89Zr-Df-IAB22M2C) is an anti-human CD8 probe targeting CD8 antigen, which can be used in the diagnosis of various cancers[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Martin Hutchings, et al. CD8 Presence and Dynamics in Glofitamab-Treated Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Using the CD8-Specific PET Tracer 89Zr-Crefmirlimab Berdoxam. Blood (2022) 140 (Supplement 1): 10733-10735.

CAS Number: 2611099-93-3

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99834-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99834-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated